Moderna Inc (MRNA) returns
Moderna returns over 5 years
$1,000 invested in Moderna five years ago was worth $642.28 at the close on October 30, 2026, with dividends reinvested: an average return of -8.5% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +15.1% | — | $1,151 | -0.9% |
| 3 months | +282.8% | — | $3,828 | +2.1% |
| Year to date | +651.8% | — | $7,518 | +11.7% |
| 1 year | +687.9% | — | $7,879 | +12.4% |
| 3 years | +199.3% | +44.1% | $2,993 | +88.5% |
| 5 years | -35.8% | -8.5% | $642.28 | +76.0% |
Moderna return by calendar year
| Year | MRNA | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +651.8% | +11.7% | +640.2% |
| 2025 | -29.1% | +17.7% | -46.8% |
| 2024 | -58.2% | +24.9% | -83.1% |
| 2023 | -44.6% | +26.2% | -70.8% |
| 2022 | -29.3% | -18.2% | -11.1% |
| 2021 | +143.1% | +28.7% | +114.4% |
| 2020 | +434.1% | +18.4% | +415.7% |
| 2019 | +28.1% | +31.2% | -3.1% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: MRNA financials
No forecast, no recommendation. This page describes Moderna Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.